Nervgen Pharma NGEN
NASDAQ NGEN
$1.35 +0.02 (+1.50%)
At close: Nov 11, 2026 · 4:00 PM EST

Nervgen Pharma (NGEN) Non-Current Assets (2024 - 2026)

Updated

Nervgen Pharma (NGEN) reported Non-Current Assets of -$9,817 for Q2 2026.

Analysis

Nervgen Pharma (NGEN) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Nervgen Pharma posted Non-Current Assets of $298,775, down 9.4% from FY2024.

  • By year, Non-Current Assets came in at $329,849 in FY2024 (-39.4%) and $544,244 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 82.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 141.07 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 110.20 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 75.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.47 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 61.69 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 34.86 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 159.99 Bn
10 Nervgen Pharma 105.93 Mn 4.82 Mn - -9,817.02
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9,817.02
Mar 31, 2026 283,748.90
Dec 31, 2025 298,774.70
Dec 31, 2024 329,849.18
Jan 1, 2024 544,243.61
API Access

Nervgen Pharma Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=NGEN&period=max&api_key=YOUR_API_KEY